Caxton Associates (New York)’s Clearside Biomedical CLSD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-35,916	Closed	-$99K	–	513
2021 Q4	$99K	Sell	35,916 -30,653	-46%	-$84.5K	0.01%	500
2021 Q3	$399K	Buy	66,569 +41,892	+170%	+$251K	0.04%	232
2021 Q2	$120K	Buy	+24,677	New	+$120K	0.01%	419